scholarly journals Cigarette Smoking and Colorectal Cancer Risk by KRAS Mutation Status Among Older Women

2012 ◽  
Vol 107 (5) ◽  
pp. 782-789 ◽  
Author(s):  
N J Samadder ◽  
Robert A Vierkant ◽  
Lori S Tillmans ◽  
Alice H Wang ◽  
Charles F Lynch ◽  
...  
2011 ◽  
Vol 140 (5) ◽  
pp. S-354
Author(s):  
Anthony Razzak ◽  
Robert Vierkant ◽  
Alice Wang ◽  
Lori S. Tillmans ◽  
Charles F. Lynch ◽  
...  

2011 ◽  
Vol 140 (5) ◽  
pp. S-353
Author(s):  
Anthony Razzak ◽  
Robert Vierkant ◽  
Alice Wang ◽  
Lori S. Tillmans ◽  
Charles F. Lynch ◽  
...  

2011 ◽  
Author(s):  
Niloy Jewel Samadder ◽  
Robert A. Vierkant ◽  
Alice Wang ◽  
Lori S. Tillmans ◽  
Charles F. Lynch ◽  
...  

2011 ◽  
Author(s):  
Anthony Razzak ◽  
Robert A. Vierkant ◽  
Alice H. Wang ◽  
Lori S. Tillmans ◽  
Charles F. Lynch ◽  
...  

Cancers ◽  
2021 ◽  
Vol 13 (9) ◽  
pp. 2148
Author(s):  
Francesco Ardito ◽  
Francesco Razionale ◽  
Lisa Salvatore ◽  
Tonia Cenci ◽  
Maria Vellone ◽  
...  

If KRAS mutation status of primary colorectal tumor is representative of corresponding colorectal liver metastases (CRLM) mutational pattern, is controversial. Several studies have reported different rates of KRAS discordance, ranging from 4 to 32%. Aim of this study is to assess the incidence of discordance and its impact on overall survival (OS) in a homogenous group of patients. KRAS mutation status was evaluated in 107 patients resected for both primary colorectal tumor and corresponding CRLM at the same institution, between 2007 and 2018. Discordance rate was 15.9%. Its incidence varied according to the time interval between the two mutation analyses (p = 0.025; Pearson correlation = 0.2) and it was significantly higher during the first 6 months from the time of primary tumor evaluation. On multivariable analysis, type of discordance (wild-type in primary tumor, mutation in CRLM) was the strongest predictor of poor OS (p < 0.001). At multivariable logistic regression analysis, the number of CRLM >3 was an independent risk factor for the risk of KRAS discordance associated with the worst prognosis (OR = 4.600; p = 0.047). Results of our study suggested that, in the era of precision medicine, possibility of KRAS discordance should be taken into account within multidisciplinary management of patients with metastatic colorectal cancer.


Biomarkers ◽  
2000 ◽  
Vol 5 (3) ◽  
pp. 225-234 ◽  
Author(s):  
Naoko Ishibe ◽  
Andrew N. Freedman ◽  
Arthur M. Michalek ◽  
Christine Iacobuziodonahue ◽  
Curtis J. Mettlin ◽  
...  

2018 ◽  
Vol 57 (12) ◽  
pp. 1727-1729
Author(s):  
Anne Gulbech Ording ◽  
Buket Öztürk ◽  
Karen-Lise Garm Spindler ◽  
Henrik Toft Sørensen ◽  
Margaret McCusker ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document